Invus — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Datawords operates a network of production studios across local markets to create and deliver localized content at scale for global brands.
AI & Machine LearningEnterprise SoftwareMarketing TechMedia & EntertainmentSector Agnostic
Co-investorsKeensight Capital
Noema Pharma develops a late-stage portfolio of oral small molecule therapeutics for people with neurological and related disorders, targeting both orphan and larger indications with significant unmet medical needs.
BiotechHealthtechMedical Devices
Ilise Lombardo(Chief Executive Officer)inVolker Knappertz(Executive Vice President of Research & Development)inMichael Samar(Chief Financial Officer)inRob Lasser(Chief Medical Officer)in
Co-investorsBioMedPartnersJeito CapitalRoche Venture FundSofinnova PartnersEQTEQT Life Sciences+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.